Bioactive Drugs from Mushrooms and Fungi

Bioactive compounds derived from fungi and mushrooms represent a vast reservoir of therapeutic agents with diverse pharmacological properties. This chapter examines the major structural classes of fungal metabolites, which include polysaccharides, terpenoids, phenolic compounds, proteins, peptides, sterols, and alkaloids. These compounds demonstrate significant biological activities across multiple therapeutic domains, encompassing antitumor, immunomodulatory, anti-inflammatory, antimicrobial, cardiovascular protective, antidiabetic, neuroprotective, and hepatoprotective effects. In line with these medicinal applications, several fungal-derived compounds have been adapted as pharmaceuticals, as exemplified by penicillin, cyclosporine, statins, cephalosporins, echinocandins, and various psychoactive compounds. Despite these advances, numerous challenges persist in the development and commercialization of fungal-derived therapeutics. Critical areas requiring attention include the need for rigorous clinical trials, optimization of extraction and production methodologies, investigation of synergistic combinations, development of advanced drug delivery systems, and elucidation of molecular mechanisms. Some significant obstacles remain in scaling up metabolite production and maintaining consistent product quality and efficacy. This chapter highlights the substantial untapped potential of fungi as a source of novel therapeutic agents and emphasizes the importance of sustained research efforts in this promising field.